Dae-Sung Kim
Directeur/Bestuurslid bij Great Orient Chemical Pte Ltd.
Actieve functies van Dae-Sung Kim
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Comptroller/Controller/Auditor | - | - |
Great Orient Chemical Pte Ltd. | Directeur/Bestuurslid | - | - |
Loopbaan van Dae-Sung Kim
Eerdere bekende functies van Dae-Sung Kim
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ISU ABXIS CO., LTD. | Directeur/Bestuurslid | 12-11-2010 | - |
Algemeen Directeur | 30-06-2014 | 24-03-2017 | |
Corporate Officer/Principal | 11-08-2011 | 30-06-2014 | |
ISU PETASYS CO., LTD. | Directeur/Bestuurslid | - | - |
Corporate Officer/Principal | - | - | |
ISU CHEMICAL CO., LTD | Directeur/Bestuurslid | 06-09-2010 | - |
Financieel Directeur/CFO | 06-09-2010 | - |
Opleiding van Dae-Sung Kim
Seoul National University | Undergraduate Degree |
Statistieken
Internationaal
Zuid-Korea | 6 |
Singapore | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sectoraal
Process Industries | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ISU CHEMICAL CO., LTD | Process Industries |
ISU ABXIS CO., LTD. | Health Technology |
ISU PETASYS CO., LTD. | Electronic Technology |
Bedrijven in privébezit | 2 |
---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Process Industries |
Great Orient Chemical Pte Ltd. |
- Beurs
- Insiders
- Dae-Sung Kim
- Ervaring